Utility of Intraoperative Intrinsic Near-Infrared Imaging for Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1

被引:0
|
作者
Yasuda, Taisei [1 ]
Kuba, Kiyomi [1 ]
Yoneyama, Eijiro [1 ]
Osaki, Masami [1 ]
机构
[1] Ageo Cent Gen Hosp, Otolaryngol Head & Neck Surg, Ageo, Japan
关键词
spy-elite (R) fluorescence imaging; parathyroidectomy; hyperparathyroidism; near-infrared fluorescence imaging; multiple endocrine neoplasia type1;
D O I
10.7759/cureus.55706
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder caused by mutations in the tumor suppressor gene MEN1 and is characterized by parathyroid, pancreatic islet, and anterior pituitary tumors. Primary hyperparathyroidism is the most characteristic finding in MEN1, and intraoperative identification and accurate removal of the diseased parathyroid glands are vital since incomplete excision results in recurrence. This case report describes a 59-year-old woman who had pancreatic islet cell tumors and pituitary tumors and underwent selective transsphenoidal adenomectomy. Based on her medical history and examination, the diagnosis of primary hyperparathyroidism in MEN1 was made, and she underwent total parathyroidectomy with autotransplantation with SPY-Elite (R) Fluorescence Imaging (Stryker Corp., Kalamazoo, MI). Intraoperative identification of the parathyroid glands using autofluorescence with real-time intrinsic near-infrared (NIR) imaging made it easier to detect all of the parathyroid hyperplasia. After the surgery, she had hypoparathyroidism and continued with her oral calcium and vitamin D supplementation to maintain normal calcium levels during follow-up. Herein, we would like to advocate that the use of parathyroid gland autofluorescence with real-time intrinsic NIR imaging may be useful for identifying parathyroid tumors in patients with primary hyperparathyroidism in MEN1.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Potential benefits of intraoperative parathyroid autofluorescence imaging in a patient with multiple endocrine neoplasia type 1 and hyperparathyroidism - A case report
    Egebaek, Christine Holm
    Lilja-Fischer, Jacob
    Rejnmark, Lars
    Rolighed, Lars
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2025, 126
  • [2] Recurrent Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1 Syndrome
    Libansky, Petr
    Carkova, Jitka
    Kushnir, Ivan
    Behanova, Magdalena Matejkova
    Procyklova, Kristyna
    Sedy, Jiri
    Vaculova, Marketa
    Vcelak, Josef
    Zikan, Vit
    Adamek, Svatopluk
    PHYSIOLOGICAL RESEARCH, 2023, 72 : S423 - S427
  • [3] PRIMARY HYPERPARATHYROIDISM IN MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A
    RAUE, F
    KRAIMPS, JL
    DRALLE, H
    COUGARD, P
    PROYE, C
    FRILLING, A
    LIMBERT, E
    LLENAS, LF
    NIEDERLE, B
    JOURNAL OF INTERNAL MEDICINE, 1995, 238 (04) : 369 - 373
  • [4] Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1
    Kluijfhout, Wouter P.
    Beninato, Toni
    Drake, Frederick Thurston
    Vriens, Menno R.
    Gosnell, Jessica
    Shen, Wen T.
    Suh, Insoo
    Liu, Chienying
    Quan-Yang Duh
    WORLD JOURNAL OF SURGERY, 2016, 40 (12) : 2964 - 2969
  • [5] Reoperative Surgery in Patients with Multiple Endocrine Neoplasia Type 1 Associated Primary Hyperparathyroidism
    Keutgen, Xavier M.
    Nilubol, Naris
    Agarwal, Sunita
    Welch, James
    Cochran, Craig
    Marx, Steve J.
    Weinstein, Lee S.
    Simonds, William F.
    Kebebew, Electron
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S701 - S707
  • [6] Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1: Individualized Management With Low Recurrence Rates
    Chen-Hsen Lee
    Ling-Ming Tseng
    Jui-Yu Chen
    Hsin-Yun Hsiao
    An-Hang Yang
    Annals of Surgical Oncology, 2006, 13 : 103 - 109
  • [7] Primary hyperparathyroidism in multiple endocrine neoplasia type 1: Individualized management with low recurrence rates
    Lee, CH
    Tseng, LM
    Chen, JY
    Hsiao, HY
    Yang, AH
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (01) : 103 - 109
  • [8] Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1
    Del Prete, M.
    Marotta, V.
    Ramundo, V.
    Marciello, F.
    Di Sarno, A.
    Esposito, R.
    Carratu, A. C.
    Di Roseto, C. De Luca
    Di Somma, C.
    Colao, A.
    Faggiano, A.
    MINERVA ENDOCRINOLOGICA, 2013, 38 (04) : 389 - 394
  • [9] Clinical aspects of hyperparathyroidism in Japanese multiple endocrine neoplasia type 1
    Sato, M
    Miyauchi, A
    Takahara, J
    BIOMEDICINE & PHARMACOTHERAPY, 2000, 54 : 86S - 89S
  • [10] Concomitant Thyroid Cancer in Patients with Multiple Endocrine Neoplasia Type 1 Undergoing Surgery for Primary Hyperparathyroidism
    Hill, Katherine A.
    Yip, Linwah
    Carty, Sally E.
    McCoy, Kelly L.
    THYROID, 2019, 29 (02) : 252 - 257